Glioma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
L
Vascular Signature Mapping of Brain Tumor Genotypes
Not yet recruiting
  • Glioma
  • Philips Achieva 7T MRI
  • +3 more
  • (no location specified)
2022-04-06
Apr 6, 2022
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1423 more
2022-04-06
Apr 6, 2022
N
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
Recruiting
  • 1p/19q Co-deletion
  • +8 more
  • IMRT (Intensity-Modulated Radiation Therapy)
  • +2 more
  • Birmingham, Alabama
  • +26 more
2022-04-04
Apr 4, 2022
C
Multimodal Machine Learning Characterization of Solid Tumors
Recruiting
  • Adenocarcinoma of Prostate
  • +5 more
  • Boston, Massachusetts
  • +1 more
2022-04-04
Apr 4, 2022
A
AB-218 Safety and Efficacy Study in Patients With IDH1 Mutant Glioma
Not yet recruiting
  • Glioma
  • (no location specified)
2022-03-29
Mar 29, 2022
E
Tumor Treating Fields for the Treatment of Brainstem Gliomas
Not yet recruiting
  • Glioma
  • Optune device
  • Atlanta, Georgia
  • +2 more
2022-03-25
Mar 25, 2022
S
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Recruiting
  • Anaplastic Astrocytoma
  • +55 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-04-01
Apr 1, 2022
K
Post-operative Imaging in High Grade Glioma: is Management Influenced?
Recruiting
  • Glioma
  • MRI
  • London, United Kingdom
    King´s College Hospital NHS Foundation trust
2022-03-30
Mar 30, 2022
N
AZD1390 in Recurrent Grade IV Glioma Patients
Recruiting
  • Glioblastoma
  • +3 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
2022-03-10
Mar 10, 2022
U
Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
Recruiting
  • Glioma
  • Hyperpolarized 13C-Pyruvate
  • Ellicott City, Maryland
    University of Maryland Medical Center
2022-03-24
Mar 24, 2022
W
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
Recruiting
  • Glioma
  • RS-fMRI
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-08
Mar 8, 2022
K
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-03-23
Mar 23, 2022
K
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
2022-03-23
Mar 23, 2022
I
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
Active, not recruiting
  • Glioma
  • Glioblastoma
  • Focused ultrasound (FUS)
  • Baltimore, Maryland
  • +3 more
2022-03-18
Mar 18, 2022
M
Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently
Recruiting
  • Glioma
  • +2 more
  • Multilingual Aphasia Examination
  • +2 more
  • New York, New York
  • +3 more
2022-03-17
Mar 17, 2022
M
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
Active, not recruiting
  • Glioma
  • Recurrent Malignant Glioma
  • Los Angeles, California
  • +15 more
2022-03-04
Mar 4, 2022
U
Non-invasive Glioma Characterization Through Molecular Imaging
Recruiting
  • Glioma
  • +4 more
  • 3T MRI Scanner
  • Miami, Florida
    University of Miami
2022-03-15
Mar 15, 2022
H
Brain Tumor Intraoperative Ultrasound Database
Not yet recruiting
  • Brain Tumor
  • +4 more
  • Ultrasound
  • Valladolid, Spain
    University Hospital Rio Hortega
2022-03-16
Mar 16, 2022
N
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
Recruiting
  • Glioma
  • +4 more
  • 3T MRI scanner
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-03-15
Mar 15, 2022
N
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
Recruiting
  • Glioma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-03-15
Mar 15, 2022
W
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-15
Mar 15, 2022
J
Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors
Recruiting
  • Advanced Solid Tumor
  • +2 more
  • ivosidenib and nivolumab
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
2022-03-14
Mar 14, 2022
N
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
Recruiting
  • Glioblastoma
  • +2 more
  • Chandler, Arizona
  • +2 more
2022-03-10
Mar 10, 2022
N
Infigratinib in Recurrent High-Grade Glioma Patients
Recruiting
  • Glioma
  • +2 more
  • Chandler, Arizona
  • +2 more
2022-03-10
Mar 10, 2022